Insider Transactions in Q2 2025 at Mannkind Corp (MNKD)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
Steven B. Binder |
SELL
Open market or private sale
|
Direct |
64,085
-6.48%
|
$256,340
$4.0 P/Share
|
|
May 27
2025
|
Burkhard Blank EVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,630
-3.25%
|
$62,520
$4.12 P/Share
|
|
May 20
2025
|
David Thomson EVP Genl Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
2,345
-0.27%
|
$9,380
$4.41 P/Share
|
|
May 20
2025
|
Steven B. Binder |
SELL
Open market or private sale
|
Direct |
12,078
-1.21%
|
$48,312
$4.4 P/Share
|
|
May 19
2025
|
David Thomson EVP Genl Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
9,536
-1.07%
|
$38,144
$4.37 P/Share
|
|
May 19
2025
|
Steven B. Binder |
SELL
Payment of exercise price or tax liability
|
Direct |
5,190
-0.52%
|
$20,760
$4.37 P/Share
|
|
May 19
2025
|
Michael Castagna Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,114
-0.99%
|
$104,456
$4.37 P/Share
|
|
May 19
2025
|
Stuart A Tross Chief People & Workpl Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,147
-0.56%
|
$24,588
$4.37 P/Share
|
|
May 14
2025
|
Dominic Marasco Pres, Endocrine Business Unit |
BUY
Grant, award, or other acquisition
|
Direct |
81,429
+11.1%
|
$162,858
$2.28 P/Share
|
|
May 14
2025
|
Michael Castagna Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+1.01%
|
$108,000
$4.56 P/Share
|
|
May 14
2025
|
Anthony C Hooper |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.05%
|
$100,000
$4.56 P/Share
|
|
May 13
2025
|
Steven B. Binder |
SELL
Open market or private sale
|
Direct |
80,144
-7.37%
|
$320,576
$4.69 P/Share
|
|
May 13
2025
|
David Thomson EVP Genl Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
119,000
+11.78%
|
-
|
|
May 13
2025
|
David Thomson EVP Genl Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
32,179
-4.0%
|
$128,716
$4.68 P/Share
|
|
May 13
2025
|
Michael Castagna Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
428,000
+14.08%
|
-
|
|
May 13
2025
|
Stuart A Tross Chief People & Workpl Officer |
BUY
Grant, award, or other acquisition
|
Direct |
119,000
+9.79%
|
-
|
|
May 13
2025
|
Sanjay R Singh EVP Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
119,000
+19.02%
|
-
|
|
May 13
2025
|
Christopher B Prentiss Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
119,000
+25.2%
|
-
|
|
May 12
2025
|
Steven B. Binder |
SELL
Payment of exercise price or tax liability
|
Direct |
93,871
-4.0%
|
$375,484
$4.56 P/Share
|
|
May 12
2025
|
David Thomson EVP Genl Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
130,837
-7.09%
|
$523,348
$4.56 P/Share
|
|
May 12
2025
|
Michael Castagna Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
369,848
-7.34%
|
$1,479,392
$4.56 P/Share
|
|
May 12
2025
|
Stuart A Tross Chief People & Workpl Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
96,775
-4.54%
|
$387,100
$4.56 P/Share
|
|
May 10
2025
|
Steven B. Binder |
BUY
Grant, award, or other acquisition
|
Direct |
105,600
+8.21%
|
-
|
|
May 10
2025
|
David Thomson EVP Genl Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
105,600
+10.14%
|
-
|
|
May 10
2025
|
Michael Castagna Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
298,560
+10.47%
|
-
|
|
May 10
2025
|
Stuart A Tross Chief People & Workpl Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,600
+8.96%
|
-
|
|
Apr 04
2025
|
Michael Castagna Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
39,500
-1.72%
|
-
|